4106 Zinc hairpin stack
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 2 | 0.4 | 4.55× | not tested | |
| Homogeneous metal compounds | 4 | 1.9 | 2.07× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 1.1 | 0.92× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 3 |
| DB01842 | PAP | 3'-Phosphate-Adenosine-5'-Diphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 14 |
| PLM | PALMITIC ACID | 3 |
| NAmetal | SODIUM ION | 2 |
| OLB | (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 2 |
| PAP | 3'-PHOSPHATE-ADENOSINE-5'-DIPHOSPHATE | 2 |
| PKZ | Palmitoyl-CoA | 2 |